Literature DB >> 2043573

Dominant cone dystrophy starting with blue cone involvement.

M J van Schooneveld1, L N Went, J A Oosterhuis.   

Abstract

The results of ophthalmological and colour vision studies are reported on 13 patients from a family with a dominant cone dystrophy spanning seven generations. The onset of visual deterioration occurred in the third or fourth decade. In the early stages of the disease, when visual acuity is still close to normal, a severe defect in the blue sensitivity is already present, as measured by spectral sensitivity curves and other tests suitable for the detection of tritan defects. In our opinion this condition represents a distinct entity with autosomal dominant inheritance.

Entities:  

Mesh:

Year:  1991        PMID: 2043573      PMCID: PMC1042376          DOI: 10.1136/bjo.75.6.332

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Design of diagnostic tests for congenital and acquired colour vision defects.

Authors:  J Birch-Cox
Journal:  Mod Probl Ophthalmol       Date:  1976

2.  Color matching and foveal densitometry in patients and carriers of an X-linked progressive cone dystrophy.

Authors:  J E Keunen; J A van Everdingen; L N Went; J A Oosterhuis; D van Norren
Journal:  Arch Ophthalmol       Date:  1990-12

3.  Autosomal dominantly inherited macular dystrophy with preferential short-wavelength sensitive cone involvement.

Authors:  G H Bresnick; V C Smith; J Pokorny
Journal:  Am J Ophthalmol       Date:  1989-09-15       Impact factor: 5.258

4.  Molecular genetics of inherited variation in human color vision.

Authors:  J Nathans; T P Piantanida; R L Eddy; T B Shows; D S Hogness
Journal:  Science       Date:  1986-04-11       Impact factor: 47.728

5.  Progressive cone dystrophy.

Authors:  H Ripps; K G Noble; V C Greenstein; I M Siegel; R E Carr
Journal:  Ophthalmology       Date:  1987-11       Impact factor: 12.079

6.  Increment spectral sensitivity of hemizygotes and heterozygotes for different classes of colour vision.

Authors:  E C de Vries-de Mol; L N Went; D van Norren; L C Pols
Journal:  Mod Probl Ophthalmol       Date:  1978

7.  Cone dystrophy, nyctalopia, and supernormal rod responses. A new retinal degeneration.

Authors:  P Gouras; H M Eggers; C J MacKay
Journal:  Arch Ophthalmol       Date:  1983-05

8.  New test for the detection of tritan defects evaluated in two surveys.

Authors:  D van Norren; L N Went
Journal:  Vision Res       Date:  1981       Impact factor: 1.886

9.  An electroretinographic and molecular genetic study of X-linked cone degeneration.

Authors:  E Reichel; A M Bruce; M A Sandberg; E L Berson
Journal:  Am J Ophthalmol       Date:  1989-11-15       Impact factor: 5.258

10.  The genetics of tritan disturbances.

Authors:  L N Went; N Pronk
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

View more
  8 in total

1.  Dominant cone dystrophy starting with blue cone involvement.

Authors:  A Pinckers
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

2.  Progressive cone dystrophy with deutan genotype and phenotype.

Authors:  Hendrik P N Scholl; Jan Kremers; Dorothea Besch; Eberhart Zrenner; Herbert Jägle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-05       Impact factor: 3.117

3.  X linked progressive cone dystrophy with specific attention to carrier detection.

Authors:  J A van Everdingen; L N Went; J E Keunen; J A Oosterhuis
Journal:  J Med Genet       Date:  1992-05       Impact factor: 6.318

4.  Late onset dominant cone dystrophy with early blue cone involvement.

Authors:  L N Went; M J van Schooneveld; J A Oosterhuis
Journal:  J Med Genet       Date:  1992-05       Impact factor: 6.318

5.  What young people think and do when the option for cystic fibrosis carrier testing is available.

Authors:  J Mitchell; C R Scriver; C L Clow; F Kaplan
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

6.  Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners.

Authors:  M E Mennie; M E Compton; A Gilfillan; W A Liston; I Pullen; D A Whyte; D J Brock
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

7.  Novel TTLL5 Variants Associated with Cone-Rod Dystrophy and Early-Onset Severe Retinal Dystrophy.

Authors:  Vasily Smirnov; Olivier Grunewald; Jean Muller; Christina Zeitz; Carolin D Obermaier; Aurore Devos; Valérie Pelletier; Béatrice Bocquet; Camille Andrieu; Jean-Louis Bacquet; Elodie Lebredonchel; Saddek Mohand-Saïd; Sabine Defoort-Dhellemmes; José-Alain Sahel; Hélène Dollfus; Xavier Zanlonghi; Isabelle Audo; Isabelle Meunier; Elise Boulanger-Scemama; Claire-Marie Dhaenens
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

8.  Two siblings with late-onset cone-rod dystrophy and no visible macular degeneration.

Authors:  Hiroyuki Sakuramoto; Kazuki Kuniyoshi; Kazushige Tsunoda; Masakazu Akahori; Takeshi Iwata; Yoshikazu Shimomura
Journal:  Clin Ophthalmol       Date:  2013-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.